![Bruce F. Scharschmidt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bruce F. Scharschmidt
Directeur/Membre du Conseil chez PharmAkea, Inc.
Provenance du réseau au premier degré de Bruce F. Scharschmidt
Entité | Type d'entité | Industrie | |
---|---|---|---|
Umecrine Cognition AB
![]() Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden.
7
| Holding Company | Pharmaceuticals: Major | 7 |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bruce F. Scharschmidt via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Glycomed, Inc.
![]() Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BIO-TECHNE CORPORATION | Biotechnology | Director/Board Member | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Modus Therapeutics AB
![]() Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
Svenska Vaccinfabriken Produktion AB
![]() Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Fundação Armando Alvares Penteado | College/University | Undergraduate Degree | |
National University | College/University | Masters Business Admin | |
IMED AB
![]() IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Chief Executive Officer | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Founder | |
DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Umea Universitet | College/University | Corporate Officer/Principal | |
Umecrine AB
![]() Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Biotechnology | Founder | |
Spinogenix, Inc.
![]() Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member | |
Amydis, Inc.
![]() Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
Lunac Therapeutics Ltd.
![]() Lunac Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lunac Therapeutics Ltd. engages in the identification and development of anticoagulants. The company was founded by Helen Philippou and Richard Foster on April 18, 2018 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
The University of Sheffield | College/University | Doctorate Degree | |
SAB BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carleton University | College/University | Undergraduate Degree | |
Lion Bioscience, Inc.
![]() Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
AIK FOTBOLL AB | Movies/Entertainment | Director of Finance/CFO | |
Stockholm School of Economics | College/University | Masters Business Admin | |
AnaCardio AB
![]() AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member | |
University of Lund | College/University | Doctorate Degree | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree | |
MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nereid Therapeutics, Inc.
![]() Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 22 |
Suède | 19 |
Royaume-Uni | 4 |
Canada | 3 |
Brésil | 2 |
Sectorielle
Health Technology | 25 |
Consumer Services | 11 |
Commercial Services | 7 |
Finance | 5 |
Retail Trade | 2 |
Opérationnelle
Director/Board Member | 58 |
Corporate Officer/Principal | 33 |
Chief Executive Officer | 17 |
Chief Tech/Sci/R&D Officer | 11 |
Chairman | 11 |
Relations les plus connectées
- Bourse
- Insiders
- Bruce F. Scharschmidt
- Connexions Sociétés